David Kavanagh, Head of the Human Resources Office at the International Agency for Research on Cancer, shared on LinkedIn:

“Globally, there were an estimated 2 206 771 new cases of lung cancer in 2020: 1 435 943 in males and 770 828 in females. Among males, an estimated 560 108 (39%) of all lung cancer cases were adenocarcinoma, 351 807 (25%) were squamous cell carcinoma, 163 862 (11%) were small-cell carcinoma, and 115 322 (8%) were large-cell carcinoma. Among females, an estimated 440 510 (57%) of all lung cancer cases were adenocarcinoma, 91 070 (12%) were squamous cell carcinoma, 68 224 (9%) were small-cell carcinoma, and 49 246 (6%) were large-cell carcinoma.

A new study – a collaboration between IARC – International Agency for Research on Cancer / World Health Organization and Guangdong Medical College (China) – quantifies for the first time the global burden of lung cancer incidence for the four main histological subtypes, documenting the substantial variations across world regions and their constituent countries. The study was published in The Lancet Oncology.”

For the article click here.
Source: David Kavanagh/LinkedIn